✓ Last verified: February 17, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Relievus Pain Management’s Pennsauken location serves Camden County with IV ketamine infusion therapy. Led by board-certified anesthesiologists Dr. Lee and Dr. Purewal, this office offers 45–60 minute ketamine infusions for depression, anxiety, PTSD, chronic pain, CRPS, and insomnia, convenient for patients near Camden and the Delaware River corridor.
| Google Reviews | ⭐ Multi-location NJ network |
| Location | Pennsauken, New Jersey |
| Address | 4307 Westfield Avenue, Pennsauken, NJ 08110 |
| Phone | (888) 985-2727 |
| Website | relievus.com |
| Treatments | IV Ketamine Infusions, Pain Management |
| Conditions Treated | Depression, Anxiety, PTSD, CRPS, Chronic Pain, Insomnia |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic for details |
| KAP Available | Not specified |
| Clinical Lead | Dr. Lee & Dr. Purewal (Board-Certified Anesthesiologists) |
HealingMaps Take: Pennsauken gives Camden-area residents a close Relievus option for ketamine therapy. Confirm ketamine availability at this location when scheduling.
Market Position: Relievus Pain Management is an IV-ketamine-focused clinic in the Pennsauken metro — the most common cash-pay protocol in the HealingMaps verified directory.
Industry pricing reference. Relievus Pain Management has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Camden County, NJ, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
23.8% of ketamine inquiries to HealingMaps arrive between midnight and 6 AM — a late-night pattern that underscores how often treatment-resistant depression symptoms peak when clinics are closed. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Relievus Pain Management treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Relievus Pain Management treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Relievus Pain Management treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Relievus Pain Management treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Relievus Pain Management treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply